Unoprostone isopropyl ester darkens iris color in pigmented rabbits with sympathetic denervation.
OBJECTIVE
Unoprostone isopropyl ester (unoprostone) -induced iris color darkening was evaluated in a rabbit model using a cyclooxygenase inhibitor, an alpha(1)-adrenergic antagonist, and sympathetic denervation.


METHODS
Dutch-belted rabbits were divided into five groups based on type of surgery and eyedrop treatment to both eyes: (1) sham surgery (n = 7); (2) bilateral superior cervical ganglionectomy (SCGx, n = 7); (3) SCGx plus flurbiprofen 0.03% (n = 7); (4) SCGx plus thymoxamine 0.5% (n = 6); and (5) SCGx plus flurbiprofen and thymoxamine (n = 6). All rabbits were treated with unoprostone 0.12% to one eye and its vehicle to the contralateral eye twice daily for 43 weeks after SCGx. Periodic color photographs of paired eyes were scored for difference in eye color. Iris melanin and aqueous humor protein were measured at week 43.


RESULTS
Twenty-three of the 26 rabbits with bilateral SCGx and unilateral unoprostone treatment demonstrated a darker iris color on the unoprostone-treated side. The average scores (demonstrating difference in iris color) comparing photographs of treated versus control eyes in the four SCGx groups were higher than those in the sham surgery group (P < 0.03), and higher than at week 0 (P < 0.001). The group pretreated with flurbiprofen and thymoxamine had the highest score of all groups. The aqueous humor protein in unoprostone-treated eyes was higher (P < or = 0.0001) than in vehicle-treated eyes. The melanin content of irides of the denervated groups was higher (P < or = 0.01) in unoprostone-treated than in vehicle-treated eyes.


CONCLUSIONS
Unoprostone produced iris color darkening in pigmented rabbit eyes with sympathetic denervation. Pretreatment with flurbiprofen and thymoxamine appeared to enhance this effect but this was not statistically demonstrated by the study.
Zhan
Gui-Lin
GL
Department of Ophthalmology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Toris
Carol B
CB
Meza
Jane L
JL
Camras
Carl B
CB
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001082:Aqueous Humor / Q000378:metabolism; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D015237:Dinoprost / Q000031:analogs & derivatives* / Q000494:pharmacology*; D004952:Esters / Q000494:pharmacology*; D005127:Eye Color / Q000187:drug effects*; D005136:Eye Proteins / Q000378:metabolism; D005480:Flurbiprofen / Q000494:pharmacology; D007498:Iris / Q000187:drug effects* / Q000378:metabolism; D008543:Melanins / Q000378:metabolism; D013948:Moxisylyte / Q000494:pharmacology; D010858:Pigmentation; D011292:Premedication; D011817:Rabbits; D017783:Superior Cervical Ganglion; D013562:Sympathectomy
D000317:Adrenergic alpha-Antagonists; D016861:Cyclooxygenase Inhibitors; D004952:Esters; D005136:Eye Proteins; D008543:Melanins; D005480:Flurbiprofen; C072630:isopropyl unoprostone; D015237:Dinoprost; D013948:Moxisylyte